Paul Jacques Zufferey
Overview
Explore the profile of Paul Jacques Zufferey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chapelle C, Le Teuff G, Zufferey P, Laporte S, Ollier E
Res Synth Methods
. 2023 Oct;
15(1):117-129.
PMID: 37846195
The number of meta-analyses of aggregate data has dramatically increased due to the facility of obtaining data from publications and the development of free, easy-to-use, and specialised statistical software. Even...
2.
Chapelle C, Ollier E, Bonjean P, Locher C, Zufferey P, Cucherat M, et al.
J Clin Epidemiol
. 2023 Aug;
162:98-106.
PMID: 37648071
Objectives: To perform an overview of the overlap of systematic reviews (SRs) assessing direct oral anticoagulants and characterize these reviews in terms of bias and methodological quality (PROSPERO: CRD42022316273). Study...
3.
Grange L, Chapelle C, Ollier E, Zufferey P, Douillet D, Killian M, et al.
Anaesth Crit Care Pain Med
. 2022 Sep;
41(6):101155.
PMID: 36087698
Purpose: Venous thromboembolism (VTE) causes significant morbidity and mortality in patients with traumatic injuries, despite thromboprophylaxis. To decrease both thrombotic and bleeding risks, some authors suggest adjusting the thromboprophylactic doses...
4.
Zufferey P, Dupont A, Lanoiselee J, Bauters A, Poissy J, Goutay J, et al.
Thromb Res
. 2021 Jul;
205:120-127.
PMID: 34311154
Background: In intensive-care unit (ICU) patients, pathophysiological changes may affect the pharmacokinetics of enoxaparin and result in underdosing. Objectives: To develop a pharmacokinetic model of enoxaparin to predict the time-exposure...
5.
Zufferey P, Lanoiselee J, Graouch B, Vieille B, Delavenne X, Ollier E
Anesthesiology
. 2020 Dec;
134(2):165-178.
PMID: 33316069
Background: It is unclear whether high-dose regimens of tranexamic acid in cardiac surgery (total dose, 80 to 100 mg/kg) confer a clinical advantage over low-dose regimens (total dose, approximately 20...
6.
Chapelle C, Rosencher N, Zufferey P, Mismetti P, Cucherat M, Laporte S
Arthroscopy
. 2014 May;
30(8):987-96.
PMID: 24813323
Purpose: To assess the efficacy of low-molecular-weight heparin (LMWH) venous thromboprophylaxis in patients with transient reduced mobility in the non-major orthopaedic setting. Methods: A meta-analysis was conducted using data from...
7.
Merquiol F, Montelimard A, Nourissat A, Molliex S, Zufferey P
Reg Anesth Pain Med
. 2013 Jul;
38(5):398-402.
PMID: 23881179
Background And Objectives: Regional anesthesia preserves perioperative immune competence and may reduce the risk of recurrence and metastasis after cancer surgery. Cervical epidural anesthesia provides adequate analgesia for head and...
8.
Zufferey P, Samama C, Rosencher N
Thromb Haemost
. 2010 Oct;
104(6):1083-4.
PMID: 20886198
No abstract available.